Internal Medicine, Pulmonary Disease · Dunmore, PA
NPI
1043217136
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1000 Meade St, Ste 200
Dunmore, PA, 18512
Phone (570) 496-0300
Medicare paid, 2024
$218K
4,243 services
Medicare patients, 2024
654
Average age 74
Drug cost, 2024
$3.5M
5,140 prescriptions
Company payments, 2024
$1,105
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory E Cali was code 99214 (office e&m - established), 787 times for 465 patients. In total Gregory E Cali billed 4,243 services in 35 codes, and Medicare paid $218K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 787 | 465 | $87.32 | $69K |
| 99213 Office E&M - Established | Office | 198 | 182 | $55.75 | $11K |
| 94060 Pulmonary Function Testing | Office | 90 | 90 | $27.32 | $2,459 |
| 94729 Pulmonary Function Testing | Office | 83 | 83 | $39.88 | $3,310 |
| 94010 Pulmonary Function Testing | Office | 76 | 75 | $19.00 | $1,444 |
| 99204 Office E&M - New | Office | 60 | 60 | $111.41 | $6,685 |
| 99215 Office E&M - Established | Office | 40 | 39 | $111.65 | $4,466 |
| G0008 Administration of influenza virus vaccine | Office | 39 | 39 | $29.40 | $1,147 |
| 90662 Vaccine Product | Office | 38 | 37 | $81.04 | $3,079 |
| 99442 Telephone Services | Office | 30 | 30 | $58.12 | $1,744 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 27 | 27 | $63.03 | $1,702 |
| 95012 Pulmonary | Office | 25 | 25 | $12.22 | $305 |
| 95810 Sleep Study | Office | 24 | 24 | $89.68 | $2,152 |
| 95811 Sleep Study | Office | 23 | 23 | $83.05 | $1,910 |
| 99443 Telephone Services | Office | 23 | 23 | $72.18 | $1,660 |
By year: 2022 $276K for 4,658 services; 2023 $348K for 7,095 services; 2024 $218K for 4,243 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory E Cali prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 819 prescriptions and refills. In total Gregory E Cali wrote 5,140 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 819 | 1,090 | 162 | $678K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 510 | 675 | 169 | $21K |
| Montelukast Sodium Generic | 405 | 850 | 91 | $4,824 |
| Breo Ellipta Fluticasone/Vilanterol | 321 | 413 | 66 | $161K |
| Prednisone Generic | 252 | 276 | 100 | $840 |
| Azithromycin Generic | 215 | 271 | 79 | $2,017 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 172 | 207 | 45 | $128K |
| Spiriva Respimat Tiotropium Bromide | 171 | 233 | 40 | $118K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 169 | 215 | 32 | $96K |
| Ventolin Hfa Albuterol Sulfate | 138 | 177 | 41 | $11K |
| Advair Hfa Fluticasone Propion/Salmeterol | 130 | 178 | 32 | $62K |
| Xolair Omalizumab | 117 | 117 | 11 | $522K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 109 | 157 | 29 | $19K |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 99 | 114 | 39 | $6,389 |
| Incruse Ellipta Umeclidinium Bromide | 78 | 84 | 18 | $29K |
Brand drugs: 3,267 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Gregory E Cali $1,105 ($1,105 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $236.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 10 | $236 |
| Genzyme Corporation SNY | 9 | $197 |
| GlaxoSmithKline, LLC. GSK | 13 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $112 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $79.99 |
| Philips North America LLC PHG | 3 | $61.87 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $52.62 |
| Merck Sharp & Dohme LLC MRK | 2 | $44.56 |
| Axsome Therapeutics, Inc. AXSM | 2 | $44.53 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $34.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.